Clinic Benefits Of Sequential Three Step Empirical Therapy In Chronic Cough Management
Main Category: Respiratory / AsthmaArticle Date: 23 May 2008 - 5:00 PDT
In this clinical study, the authors used an empirical 3-step therapy to treat patients with chronic cough and successfully relieved cough in 88% of the study patients.
This sequential therapy is designed in such a way that the common cough is treated first.
By increasing the success rate of this initial treatment as well as enhancing patient compliance, researchers were able to decrease the duration of treatment.
This simple approach can achieve a similar cough control rate as those of specific cause-directed treatment after full laboratory testing, thereby eliminating the need for complex laboratory testing and costs.
"Clinical benefit of sequential three-step empirical therapy in the management of chronic cough"
Li Yu, Zhongmin Qiu, Hanjing Lü, Weili Wei, Cuiqin Shi
Click here to view abstract online
Respirology is a journal of international standing, publishing peer-reviewed articles of scientific excellence in clinical and experimental respiratory biology and disease and its related fields of research including thoracic surgery, internal medicine, immunology, intensive and critical care, epidemiology, cell and molecular biology, pathology, pharmacology and physiology.
Respirology
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |



